| [1] | Mas-Coma S, Valero MA, Bargues MD. Human and animal fascioliasis: Origins and worldwide evolving scenario[J]. Clin Microbiol Rev, 2022, 35(4): e0008819. | | [2] | Siles-Lucas M, Becerro-Recio D, Serrat J, et al. Fascioliasis and fasciolopsiasis: Current knowledge and future trends[J]. Res Vet Sci, 2021, 134: 27-35. | | [3] | 姚嘉文, 贾铁武. 片形吸虫的全球分布及传播[J]. 中国血吸虫病防治杂志, 2022, 34(6): 654-658. | | | Yao JW, Jia TW. Global distribution and transmission of Fasciola[J]. Chin J Schisto Control, 2022, 34(6): 654-658. (in Chinese) | | [4] | 袁晓丹, 王春仁, 朱兴全, 等. 片形吸虫病的危害与防制[J]. 中国动物传染病学报, 2019, 27(2): 110-113. | | | Yuan XD, Wang CR, Zhu XQ, et al. Harm and prevention of Fasciola[J]. Chin J Vet Parasitol, 2019, 27(2): 110-113. (in Chinese) | | [ 5] | Huang LH, Li FX, Su HY, et al. Emerging human fascioliasis: A retrospective study of epidemiological findings in Dali, Yunnan Province, China (2012-2021)[J]. Med Sci Monit, 2023, 29: e940581. | | [6] | 汪平帮, 黄竹英, 王宏, 等. 急性肝片形吸虫病1例[J]. 中国血吸虫病防治杂志(中英文), 2025(1): 104-106. | | | Wang PB, Huang ZY, Wang H, et al. Acute fascioliasis hepatica: A case report[J]. Chin J Schisto Control, 2025(1): 104-106. (in Chinese) | | [7] | 涂奎, 赵礼金, 顾进, 等. 人胆总管肝片形吸虫病1例[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(1): 封三. | | | Tu K, Zhao LJ, Gu J, et al. Fasciola hepatica in human common bile duct: A case report[J]. Chin J Parasitol Parasit Dis, 2021, 39(1): Inside back page. (in Chinese) | | [8] | 陆燕, 何名聪, 覃小升, 等. 广西来宾市1例片形吸虫病诊治及流行病学调查[J]. 中国热带医学, 2024, 24(3): 362-364. | | | Lu Y, He MC, Qin XS, et al. Diagnosis, treatment and epidemiological investigation of a case of Fasciola in Laibin City, Guangxi[J]. China Trop Med, 2024, 24(3): 362-364. (in Chinese) | | [9] | Ai L, Chen JX, Cai YC, et al. Prevalence and risk factors of fascioliasis in China[J]. Acta Trop, 2019, 196: 180-188. | | [10] | 张伟娜, 顾伟, 焦建明, 等. 15例片形吸虫病患者临床资料分析[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(2): 207-212. | | | Zhang WN, Gu W, Jiao JM, et al. Clinical data analysis of 15 patients with Fasciola[J]. Chin J Parasitol Parasit Dis, 2019, 37(2): 207-212. (in Chinese) | | [11] | 国家卫生和计划生育委员会. 片形吸虫病诊断 WS/T 566—2017[S]. 北京: 中国标准出版社, 2017: 1-11. | | | National Health and Family Planning Commission. Diagnosis of fascioliasis: WS/T 566-2017[S]. Beijing: Standards Press of China, 2017: 1-11. (in Chinese) | | [12] | Rumgay H, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040[J]. J Hepatol, 2022, 77(6): 1598-1606. | | [13] | Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. | | [14] | Zhou MG, Wang HD, Zeng XY, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204): 1145-1158. | | [15] | 王远珍, 田仁海, 张映媛, 等. 原发性肝癌干预前并发肝性胸腔积液的危险因素及列线图预测模型构建[J]. 临床肝胆病杂志, 2025, 41(1): 75-83. | | | Wang YZ, Tian RH, Zhang YY, et al. Risk factors of hepatocellular carcinoma complicated with hepatic pleural effusion before intervention and construction of nomogram prediction model[J]. J Clin Hepatol, 2025, 41(1): 75-83. (in Chinese) | | [16] | 中华人民共和国国家卫生健康委员会医政司. 原发性肝癌诊疗指南(2024年版)[J]. 协和医学杂志, 2024, 15(3): 532-558. | | | Medical Administration Bureau, National Health Commission of the People’s Republic of China. Guidelines for diagnosis and treatment of primary liver cancer (2024 edition)[J]. Med J Peking Union Med Coll Hosp, 2024, 15(3): 532-558. (in Chinese) | | [17] | Sankar K, Gong J, Osipov A, et al. Recent advances in the management of hepatocellular carcinoma[J]. Clin Mol Hepatol, 2024, 30(1): 1-15. | | [18] | Leerapun A, Puasripun S, Kijdamrongthum P, et al. Human fascioliasis presenting as liver abscess: Clinical characteristics and management[J]. Hepatol Int, 2021, 15(3): 804-811. | | [19] | 陈永胜, 王军, 丁璐璐, 等. 中国及全球肝癌流行特征分析[J]. 中华肿瘤杂志, 2025, 47(9): 858-866. | | | Chen YS, Wang J, Ding LL, et al. Epidemiological characteristics of liver cancer in China and the world[J]. Chin J Oncol, 2025, 47(9): 858-866. (in Chinese) | | [20] | Stockdale AJ, Kreuels B, Shawa IT, et al. Causes, associated exposures, and outcomes of cirrhosis and hepatocellular carcinoma in Malawi: An observational cohort and case-control study[J]. Lancet Glob Health, 2025, 13(11): e1924-e1934. | | [21] | Wen QR, Chan KH, Shi KX, et al. Tobacco smoking and solid fuels for cooking and risk of liver cancer: A prospective cohort study of 0.5 million Chinese adults[J]. Int J Cancer, 2022, 151(2): 181-190. | | [22] | Jain D, Chaudhary P, Varshney N, et al. Tobacco smoking and liver cancer risk: Potential avenues for carcinogenesis[J]. J Oncol, 2021, 2021: 5905357. | | [23] | Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: Implications for screening, prevention and therapy[J]. Nat Rev Clin Oncol, 2023, 20(12): 864-884. | | [24] | Konyn P, Ahmed A, Kim D. Current epidemiology in hepatocellular carcinoma[J]. Expert Rev Gastroenterol Hepatol, 2021, 15(11): 1295-1307. | | [25] | Taniai M. Alcohol and hepatocarcinogenesis[J]. Clin Mol Hepatol, 2020, 26(4): 736-741. | | [26] | 缪伟刚, 周金意, 韩仁强. 全球肝癌流行数据解析[J]. 中华流行病学杂志, 2024, 45(6): 865-869. | | | Miao WG, Zhou JY, Han RQ. Analysis of global epidemic data of liver cancer[J]. Chin J Epidemiol, 2024, 45(6): 865-869. (in chinese) | | [27] | Sreeramareddy CT, Aye SN. Changes in adult smoking behaviours in ten global adult tobacco survey (GATS) countries during 2008-2018-a test of ‘hardening’hypothesis’[J]. BMC Public Health, 2021, 21(1): 1209. | | [28] | Manthey J, Shield KD, Rylett M, et al. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: A modelling study[J]. Lancet, 2019, 393(10190): 2493-2502. | | [29] | 周姝, 白冰, 张宗敏, 等. 雌激素对人肝癌细胞增殖和凋亡的影响[J]. 中国老年学杂志, 2020, 40(18): 3927-3932. | | | Zhou S, Bai B, Zhang ZM, et al. Effect of estrogen on proliferation and apoptosis of human hepatocellular carcinoma cells[J]. Chin J Gerontol, 2020, 40(18): 3927-3932. (in chinese) | | [30] | 李芹翠, 陈凤, 顾伟, 等. 云南省65例片形吸虫病临床特点[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(4): 521-523. | | | Li QC, Chen F, Gu W, et al. Clinical characteristics of 65 cases of Fasciola in Yunnan Province[J]. Chin J Parasitol Parasit Dis, 2020, 38(4): 521-523. (in chinese) | | [31] | 刘送莲, 李波, 王亚萍, 等. HBV相关早发性肝癌与迟发性肝癌的临床特征比较[J]. 临床肝胆病杂志, 2025, 41(9): 1837-1844. | | | Liu SL, Li B, Wang YP, et al. Comparison of clinical characteristics between HBV-related early-onset liver cancer and late-onset liver cancer[J]. J Clin Hepatol, 2025, 41(9): 1837-1844. (in chinese) | | [32] | 梅雪芳, 施维, 张瑶瑶, 等. 大片吸虫分泌排泄抗原对小鼠肝损伤的研究[J]. 动物医学进展, 2016, 37(12): 34-38. | | | Mei XF, Shi W, Zhang YY, et al. Study on liver injury induced by excretory antigen secreted by Fasciola gigantea in mice[J]. Prog Vet Med, 2016, 37(12): 34-38. (in Chinese) | | [33] | Zhen WC, Sun J, Bai XT, et al. Trends of alkaline phosphatase to prealbumin ratio in patients with hepatitis B linked to hepatocellular carcinoma development[J]. World J Gastroenterol, 2025, 31(2): 99349. | | [34] | Li Q, Lyu ZZ, Wang LG, et al. Albumin-to-alkaline phosphatase ratio associates with good prognosis of hepatitis B virus-positive HCC patients[J]. Onco Targets Ther, 2020, 13: 2377-2384. | | [35] | Passaro A, Al Bakir M, Hamilton EG, et al. Cancer biomarkers: Emerging trends and clinical implications for personalized treatment[J]. Cell, 2024, 187(7): 1617-1635. | | [36] | Zhou Y, Tao L, Qiu JH, et al. Tumor biomarkers for diagnosis, prognosis and targeted therapy[J]. Signal Transduct Target Ther, 2024, 9(1): 132. | | [37] | Wechsler ME, Munitz A, Ackerman SJ, et al. Eosinophils in health and disease: A state-of-the-art review[J]. Mayo Clin Proc, 2021, 96(10): 2694-2707. | | [38] | Jackson DJ, Akuthota P, Roufosse F. Eosinophils and eosinophilic immune dysfunction in health and disease[J]. Eur Respir Rev, 2022, 31(163): 210150. | | [39] | Ariyaratne A, Finney CAM. Eosinophils and macrophages within the Th2-induced granuloma: Balancing killing and healing in a tight space[J]. Infect Immun, 2019, 87(10): e00127-19. | | [40] | Aoki A, Hirahara K, Kiuchi M, et al. Eosinophils: Cells known for over 140 years with broad and new functions[J]. Allergol Int, 2021, 70(1): 3-8. | | [41] | Klion AD, Ackerman SJ, Bochner BS. Contributions of eosinophils to human health and disease[J]. Annu Rev Pathol, 2020, 15: 179-209. | | [42] | Kataoka S, Konishi Y, Nishio Y, et al. Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma[J]. DNA Cell Biol, 2004, 23(9): 549-560. | | [43] | Wang QH, Zhang ZX, Zhou H, et al. Eosinophil-associated genes are potential biomarkers for hepatocellular carcinoma prognosis[J]. J Cancer, 2024, 15(17): 5605-5621. | | [44] | 李宁宁, 李红蕊, 羊冬梅, 等. 肝巨片吸虫病患者临床、病理和影像学表现特点及其诊断价值分析[J]. 中国地方病防治杂志, 2017, 32(2): 226. | | | Li NN, Li HR, Yang DM, et al. Clinical, pathological and imaging features of patients with Fasciola hepatica and its diagnostic value[J]. Chin J Control Endem Dis, 2017, 32(2): 226. (in Chinese) |
|